Coronavirus mutated in immunocompromised patient after plasma therapy: case study
A case study involving a patient in his 70s has raised the possibility that SARS-CoV-2, the virus that causes COVID-19, could evolve in immunocompromised individuals infected over an extended period of time and treated with convalescent plasma therapy, U.K. researchers say.